Publications & Works

Publication Network
Articles 18
All (18)
SCI-E, SSCI, AHCI (17)
SCI-E, SSCI, AHCI, ESCI (18)
ESCI (1)
Scopus (18)
TRDizin (1)

1. The CeRNA role of HOTAIR: sponging MiRs to promote chemoresistance

Nademi N., ÖZFİLİZ KILBAŞ P.
Molecular Biology Reports , vol.53, no.1, 2026 (SCI-Expanded, Scopus)

2. Exploring the frontier of non-coding RNAs: biogenesis, functional diversity, and disease associations of circRNAs and tinyRNAs

Calisir H., Akcay S., Bal E., Ozfiliz-Kilbas P., Ozden B., Ayhan-Sahin B.
MOLECULAR BIOLOGY REPORTS , vol.52, no.1, 2025 (SCI-Expanded, Scopus) Sustainable Development

3. Circulating microRNA expression profiles to identify a potential link between prostate cancer and obesity

Arisan S., ÖZFİLİZ KILBAŞ P., RENCÜZOĞULLARI Ö., Unsal N. P., ÇOKER GÜRKAN A., OBAKAN YERLİKAYA P., et al.
HUMAN GENE , vol.34, 2022 (ESCI, Scopus) Sustainable Development

4. The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing

Ozfiliz Kilbas P., Alkurt G., YERLİKAYA P. O., Coker Gurkan A., Dinler Doğanay G., ARISAN E. D.
TURKISH JOURNAL OF BIOLOGY , vol.46, no.2, pp.118-147, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sustainable Development

5. CRISPR/Cas9-mediated Bag-1 knockout increased mesenchymal characteristics of MCF-7 cells via Akt hyperactivation-mediated actin cytoskeleton remodeling

Kilbas P., Can N. D., Kizilboga T., Ezberci F., Dinler Doğanay G., ARISAN E. D., et al.
PLOS ONE , vol.17, no.1, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

6. In Vitro Investigations of miR-33a Expression in Estrogen Receptor-Targeting Therapies in Breast Cancer Cells

ÖZFİLİZ KILBAŞ P., Sonmez O., YERLİKAYA P. O., ÇOKER GÜRKAN A., Palavan-Unsal N., Uysal-Onganer P., et al.
CANCERS , vol.13, no.21, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

7. Co-Chaperone Bag-1 Plays a Role in the Autophagy-Dependent Cell Survival through Beclin 1 Interaction

Turk M., Tatli O., Alkan H. F., ÖZFİLİZ KILBAŞ P., Alkurt G., Dinler Doğanay G.
MOLECULES , vol.26, no.4, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

8. Interactome analysis of Bag-1 isoforms reveals novel interaction partners in endoplasmic reticulum-associated degradation

Can N. D., Basturk E., Kizilboga T., Akçay İ. M., Dingiloglu B., Tatli O., et al.
PLOS ONE , vol.16, no.8, 2021 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

9. Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways

ÖZFİLİZ KILBAŞ P., Sonmez O., Uysal-Onganer P., Coker Gurkan A., Obakan Yerlikaya P., ARISAN E. D.
BIOLOGY-BASEL , vol.9, no.10, pp.1-18, 2020 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

10. Revealing the functional role of Bag-1 in MCF-7 breast cancer cells through CRISPR/Cas9-mediated gene knockout

ÖZFİLİZ KILBAŞ P., Arisan E. D., Dinler Doğanay G.
FEBS OPEN BIO , pp.402, 2019 (SCI-Expanded, Scopus)

11. Bag-1 silencing enhanced chemotherapeutic drug-induced apoptosis in MCF-7 breast cancer cells affecting PI3K/Akt/mTOR and MAPK signaling pathways

ÖZFİLİZ KILBAŞ P., Akçay İ. M., Dinler Doğanay G., Arisan E. D.
MOLECULAR BIOLOGY REPORTS , vol.46, no.1, pp.847-860, 2019 (SCI-Expanded, Scopus) Sustainable Development

12. Cyclin-dependent kinase inhibitors, roscovitine and purvalanol, induce apoptosis and autophagy related to unfolded protein response in HeLa cervical cancer cells

ÖZFİLİZ KILBAŞ P., Sarikaya B., YERLİKAYA P. O., ÇOKER GÜRKAN A., Arisan E. D., Temizci B., et al.
MOLECULAR BIOLOGY REPORTS , vol.45, no.5, pp.815-828, 2018 (SCI-Expanded, Scopus) Sustainable Development

13. Bag-1 silencing enhanced apoptosis via altering the ubiquitination process of Foxo3a in MCP-7 breast cancer cells

ÖZFİLİZ KILBAŞ P., Arisen E. D., Dinler Doğanay G., Unsal N. P.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , 2017 (SCI-Expanded, Scopus)

14. Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells

Arisan E. D., Ilkhan D., ÖZFİLİZ KILBAŞ P., ÇOKER GÜRKAN A., YERLİKAYA P. O., Unsal N. P.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , 2017 (SCI-Expanded, Scopus)

15. Bag-1 promotes cell survival through c-Myc-mediated ODC upregulation that is not preferred under apoptotic stimuli in MCF-7 cells

Ozfiliz P., Kizilboga T., Demir S., Alkurt G., Palavan-Unsal N., Arisan E. D., et al.
CELL BIOCHEMISTRY AND FUNCTION , vol.33, no.5, pp.293-307, 2015 (SCI-Expanded, Scopus) Sustainable Development

16. Roscovitine-treated He La cells finalize autophagy later than apoptosis by downregulating Bcl-2

ÇOKER GÜRKAN A., Arisan E. D., YERLİKAYA P. O., ÖZFİLİZ KILBAŞ P., Kose B., Bickici G., et al.
MOLECULAR MEDICINE REPORTS , vol.11, no.3, pp.1968-1974, 2015 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

17. Purvalanol A is a strong apoptotic inducer via activating polyamine catabolic pathway in MCF-7 estrogen receptor positive breast cancer cells

YERLİKAYA P. O., Arisan E. D., ÖZFİLİZ KILBAŞ P., ÇOKER GÜRKAN A., Palavan-Unsal N.
MOLECULAR BIOLOGY REPORTS , vol.41, no.1, pp.145-154, 2014 (SCI-Expanded, Scopus) Sustainable Development

18. Bag-1L is a Stress-withstand Molecule Prevents the Downregulation of Mcl-1 and c-Raf Under Control of Heat Shock Proteins in Cisplatin Treated HeLa Cervix Cancer Cells

ÖZFİLİZ KILBAŞ P., Arisan E. D., ÇOKER GÜRKAN A., YERLİKAYA P. O., Eralp T. N., Dinler Doğanay G., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.11, pp.4475-4482, 2014 (SCI-Expanded, Scopus) Sustainable Development
Papers Presented at Peer-Reviewed Scientific Conferences 32

1. Identification of the Interaction Between Foxo3a and Lipid Metabolism Proteins

SARAK İ., Aydın Y. E., ÖZFİLİZ KILBAŞ P.
TuPA Uluslararası Proteomik Kongresi // 6. Ulusal Proteomik Kongresi, Kocaeli, Turkey, 11 - 12 October 2024, (Summary Text)

2. The Effect of FoxO3a Overexpression on Breast Cancer Metabolism Through Orlistat Treatment

Aydın Y. E., Atakan M., Özcan B., ÖZFİLİZ KILBAŞ P.
TuPA Uluslararası Proteomik Kongresi // 6. Ulusal Proteomik Kongresi, Kocaeli, Turkey, 11 - 12 October 2024, (Summary Text)

3. The Relationship Between FoxO3a and Lipid Metabolism in Breast Cancer

ÖZFİLİZ KILBAŞ P., SARAK İ., Aydın Y. E., Atakan M., Özcan B.
TuPA Uluslararası Proteomik Kongresi // 6. Ulusal Proteomik Kongresi, Kocaeli, Turkey, 11 - 12 October 2024, (Summary Text)

4. CRISPR-Cas9 Aracılı Amfiregülin Baskılanmasının Melanom Hücre Çoğalması Üzerine Etkisi

Çolak D. K., ÖZFİLİZ KILBAŞ P., BOLKENT H. S.
Kanserle Mücadelede Geleceğe Yönelik Stratejiler Sempozyumu, Turkey, 05 October 2024, (Summary Text)

5. The investigation of fatty acid metabolism related to AMPKa/miR33a expression in renal cell carcinoma

ÇALIŞIR H. N., AKÇAY S., ÖZFİLİZ KILBAŞ P., RENCÜZOĞULLARI Ö., AYHAN ŞAHİN B.
2. International Workshop on Cancer and Lipidomics, Turkey, 10 - 11 September 2024, (Summary Text)

6. Deficiency of antiapoptotic Bag-1 increased mesenchymal properties of MCF-7 breast cancer cells

ÖZFİLİZ KILBAŞ P.
I. International Advances in Molecular Biology Congress, Turkey, 19 September 2022, (Summary Text)

7. Investigation of the Effect of STAT3 Inhibition on Apoptotic Process Associated with JAK/STAT Signaling Pathway in A-498 and ACHN Renal Carcinoma Cells

Yıldızhan K. Y., Aydin Y. E., ÖZFİLİZ KILBAŞ P., AYHAN ŞAHİN B., RENCÜZOĞULLARI Ö.
25th IUBMB Congress, the 46th FEBS Congress and the 15th PABMB Congress, Lisbon, Portugal, 9 - 14 July 2022, (Summary Text)

8. Examination of Fatty Acid Metabolism and Induction of Epithelial-Mesenchymal Transition pathway via modulation of miR-33a levels in Caki-1 and Caki-2 Renal Cell Carcinoma Cells

İnce İ., Kalabalıkoğlu E., AYHAN ŞAHİN B., ÖZFİLİZ KILBAŞ P., RENCÜZOĞULLARI Ö.
25th IUBMB Congress, the 46th FEBS Congress and the 15th PABMB Congress, Lisbon, Portugal, 9 - 14 July 2022, (Summary Text)

9. Investigation of the molecular effects of palbociclib and celastrol combination treatment in pancreatic cancer cells

DELİOĞLU S. Ş., GİRİTLİOĞLU Z., AYHAN ŞAHİN B., ÖZFİLİZ KILBAŞ P., RENCÜZOĞULLARI Ö.
5th Congress of SDIR: Translational Potential of Cancer Research in Serbia, Serbia, 03 December 2021, pp.1-50, (Summary Text) Sustainable Development

10. In Vitro Investigations of miR-33a Expression in Estrogen Receptor-Targeting Therapies in Breast Cancer Cells

ÖZFİLİZ KILBAŞ P., Sonmez O., OBAKAN YERLİKAYA P., ÇOKER GÜRKAN A., ÜNSAL Z. N., Uysal-Onganer P., et al.
5th Congress of SDIR: Translational Potential of Cancer Research in Serbia, Serbia, 03 December 2021, (Summary Text) Sustainable Development

11. Cisplatin and Paclitaxel Modulated the Cell Survival Potential of Prostate Cancer Cells

Kashani S., ÖZFİLİZ KILBAŞ P., OBAKAN YERLİKAYA P., ÇOKER GÜRKAN A., ARISAN E. D.
3rd International conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, 18 - 20 December 2019, (Summary Text) Sustainable Development

12. Actin disorganization is the major outcome of CRISPR-Cas9-Mediated Bag-1 Knockout MCF-7 breast cancer cells

ÖZFİLİZ KILBAŞ P., ARISAN E. D., DİNLER DOĞANAY G.
7th International Congress of the Molecular Biology Association of Turkey, İstanbul, Turkey, 27 - 29 September 2019, (Summary Text)

13. Revealing the functional role of Bag-1 in MCF-7 breast cancer cells through CRISPR/Cas9-mediated gene knockout

ÖZFİLİZ KILBAŞ P., ARISAN E. D., DİNLER DOĞANAY G.
The 44th FEBS Congress, Krakow, Poland, 6 - 11 July 2019, (Summary Text) Sustainable Development

14. Investigation the relationship between cholesterol metabolism and breast cancer through miR-33a in estrogen receptor targeting therapies

ÖZFİLİZ KILBAŞ P., Sönmez Ö., ARISAN E. D., ÇOKER GÜRKAN A., OBAKAN YERLİKAYA P., ÜNSAL Z. N.
6th International BAU Drug Design Congress, İstanbul, Turkey, 13 - 15 December 2018, (Summary Text)

15. Investigating the molecular mechanisms of paclitaxel resistance through PI3/Akt and EMT signaling pathways in MCF-7 breast cancer

Sönmez Ö., ÖZFİLİZ KILBAŞ P., ARISAN E. D., ÇOKER GÜRKAN A., OBAKAN YERLİKAYA P., ÜNSAL Z. N.
6th International BAU Drug Design Congress, İstanbul, Turkey, 13 - 15 December 2018, (Summary Text)

16. Serotonin altered receptor tyrosine signalling pathway differently in MCF-7 and MDA-MB-231 breast cancer cells

ARISAN E. D., İlkhan D., ÖZFİLİZ KILBAŞ P., ÇOKER GÜRKAN A., OBAKAN YERLİKAYA P., ÜNSAL Z. N.
The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine, Athens, Greece, 5 - 07 November 2017, vol.40, pp.27, (Summary Text)

17. Bag-1 silencing enhanced apoptosis via altering the ubiquitination process of Foxo3a in MCF-7 breast cancer cells

ÖZFİLİZ KILBAŞ P., ARISAN E. D., DİNLER DOĞANAY G., ÜNSAL Z. N.
The 22nd World Congress on Advances in Oncology and 20th International Symposium on Molecular Medicine, Athens, Greece, 5 - 07 November 2017, vol.40, pp.37, (Summary Text)

18. Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells

Aras S., Ozdemir B. S., Arisan E. D., RENCÜZOĞULLARI Ö., ÖZFİLİZ KILBAŞ P., YERLİKAYA P. O., et al.
European Biotechnology Congress, Dubrovnik, Croatia, 25 - 27 May 2017, (Summary Text) Sustainable Development

19. Serotonin, MCF-7 ve MDA-MB-231 Meme Kanseri Hücrelerinde Hücre Canlılığını, Sağkalımını ve Klonojenik Oluşumu Azaltır

İlkhan D., ÖZFİLİZ KILBAŞ P., ARISAN E. D., ÇOKER GÜRKAN A., OBAKAN YERLİKAYA P., ÜNSAL Z. N.
6. Kök Hücre Sempozyumu, İstanbul, Turkey, 05 June 2017, (Summary Text) Sustainable Development

20. FASN inhibitörü, Orlistatın Hücre Ölüm mekanizmalarına olan etkisinin LNCaP ve DU145 prostat kanseri hücrelerinde araştırılması

TOKYAY A., AKAR F. S., RENCÜZOĞULLARI Ö., ÖZFİLİZ KILBAŞ P., ARISAN E. D., OBAKAN YERLİKAYA P., et al.
6. Kök Hücre Sempozyumu, İstanbul, Turkey, 5 - 06 May 2017, (Summary Text) Sustainable Development

21. FASN inhibitörü orlistat tarafından tetiklenen apoptotik ve otofajik hücre süreçlerinin EMT aracılı olarak PC3 prostat kanseri hücrelerinde incelenmesi

ARAS S., ÖZDEMİR B. S., RENCÜZOĞULLARI Ö., ÖZFİLİZ KILBAŞ P., ARISAN E. D., OBAKAN YERLİKAYA P., et al.
6. Kök Hücre Sempozyumu, Turkey, 5 - 06 May 2017, (Summary Text) Sustainable Development

22. Celastrol’ün prostat kanseri hücrelerinde PI3K/Akt sinyal yolağı lie ilişkili olarak epitelyal-mezenkimal hücre tranzisyonuna etkisi

ÇOBAN M., SEVGİN B., ŞENTÜRK K., RENCÜZOĞULLARI Ö., ÖZFİLİZ KILBAŞ P., ARISAN E. D., et al.
6. Kök Hücre Sempozyumu, Turkey, 5 - 06 May 2017, (Summary Text) Sustainable Development

23. CDK Inhibitors Roscovitine and purvalanol induced ER stress-mediated apoptosis in HeLa Cervical Cancer Cells Related with induction of oxidative stress

SARIKAYA B., ÖZFİLİZ KILBAŞ P., ARISAN E. D., ÇOKER GÜRKAN A., OBAKAN YERLİKAYA P., ÜNSAL Z. N.
6. Multidisipline Kanser Araştırma Kongresi, Konya, Turkey, 27 - 30 October 2016, pp.174, (Summary Text) Sustainable Development

24. Knock-down of anti-apoptotic Bag-1 modulated the regulation of cell survival pathways in breast cancer

ÖZFİLİZ KILBAŞ P., Arisan E. D., Dinler Doğanay G.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, pp.158-159, (Summary Text)

25. Suppression of polyamine biosynthesis decreased Bag 1 expression levels to alter cell proliferation survival in HeLa cervical cells

ÖZFİLİZ P., DİNLER DOĞANAY G., ARISAN E. D., ÜNSAL Z. N.
Gordon Conference Polyamines: Role of Polyamines in Biology and Disease, Waterville Valley, United States Of America, 6 - 10 May 2015, (Summary Text)

26. Silencing of Bag-1 enhanced the cisplatin or paclitaxel-induced apoptosis via regulating PI3K, Akt and MAPK signaling axis in MCF-7 breast cancer cells

ÖZFİLİZ KILBAŞ P., ARISAN E. D., OBAKAN YERLİKAYA P., ÇOKER GÜRKAN A., DİNLER DOĞANAY G., ÜNSAL Z. N.
2nd EACR Sponsored 2nd Anticancer Agents Congress 5th Mutlidisciplinary Cancer Research Congress, BODRUM, Turkey, 23 - 27 April 2014, pp.145, (Summary Text) Sustainable Development

27. Bag-1 silencing modulated MAPK signaling cascade to alter drug-induced polyamine metabolic regulation in MCF-7 breast cancer cells

ÖZFİLİZ KILBAŞ P., ARISAN E. D., ÜNSAL Z. N., DİNLER DOĞANAY G.
Gordon Conference Polyamines: Role of Polyamines in Biology and Disease, Waterville Valley, United States Of America, 16 June 2013, (Summary Text) Sustainable Development

28. The Potential Role of Bag-1 in cisplatin or paclitaxel-induced Apoptosis

ÖZFİLİZ KILBAŞ P., ARISAN E. D., DİNLER DOĞANAY G.
First International Congress of the Molecular Biology Association of Turkey, İstanbul, Turkey, 02 November 2012, (Summary Text)

29. Bag-1 is an Oncogenic Factor Induces Cell Survival by Increasing Polyamine Content

Demir S., ÖZFİLİZ KILBAŞ P., ARISAN E. D., DİNLER DOĞANAY G.
International Congress on Polyamines-Polyamines: Biological and Clinical Perspectives, İstanbul, Turkey, 02 September 2012, (Summary Text)

30. Bag-1 Prevented Drug-Induced Apoptosis by Modulating Polyamine Metabolism in MCF-7 Cells

ÖZFİLİZ KILBAŞ P., Demir S., ARISAN E. D., DİNLER DOĞANAY G.
International Congress on Polyamines-Polyamines: Biological and Clinical Perspectives, İstanbul, Turkey, 2 - 07 September 2012, pp.213, (Summary Text)

31. Purvalanol A is a Strong Apoptotic Inducer via Activating Polyamine Catabolic Pathway in MCF-7 Estrogen Receptor Breast Cancer Cells

OBAKAN YERLİKAYA P., ÖZFİLİZ KILBAŞ P., ARISAN E. D., ÇOKER GÜRKAN A., ÜNSAL Z. N.
EMBO Young Scientist Forum, İstanbul, Turkey, 14 - 16 June 2012, (Summary Text)

32. The investigation of the functional role of Bag-1 in paclitaxel-induced apoptosis related with polyamines

ÖZFİLİZ KILBAŞ P., ARISAN E. D., DİNLER DOĞANAY G., ÜNSAL Z. N.
Gordon Conferences: Polyamines, Waterville Valley, United States Of America, 18 June 2011, (Summary Text)
Books 2

1. Investigating Cancer Tumor Microenvironment In vitro: Co-Culture Studies on Adipocytes and Cancer Cells

Rencüzoğulları Ö., Özfiliz Kılbaş P., Bal E., Ayhan Şahin B.
in: Technologies in Cell Culture - A Journey From Basics to Advanced Applications, Prof. Soumya Basu,Dr. Amit Ranjan,Dr. Subhayan Sur, Editor, IntechOpen, London, pp.1-21, 2023 Creative Commons License

2. Investigating Cancer Tumor Microenvironment In vitro: Co-Culture Studies on Adipocytes and Cancer Cells

Özfiliz Kilbaş P.
in: Technologies in Cell Culture - A Journey From Basics to Advanced Applications, Prof. Soumya Basu, Editor, IntechOpen, London, pp.1-21, 2023
Metrics

Publication

56

Publication (WoS)

20

Publication (Scopus)

18

Citation (WoS)

125

H-Index (WoS)

7

Citation (Scopus)

125

H-Index (Scopus)

8

Citation (Scholar)

3

H-Index (Scholar)

1

Project

10

Thesis Advisory

6

Open Access

8
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING